Cancer Drug articles & resources on Made-in-China.com

Hutchison China Meditech Had Enrolled Patients for a Study of Colorectal Cancer

Sep 11, 2014

Amid daily updates from the pharmaceuticals industry on the latest clinical trials, last week's announcement by Hutchison China MediTech that it had enrolled patients for a study of colorectal cancer was hardly cause for excitement. But ...

Tags: Health, Medicine, Chinese Pharma

Clinical Trials Investigating New Uses Have Produced Mixed Results

Feb 19, 2014

Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...

Tags: Health, Medicine

Noted Oncologists Call for a Single-Payer U.S.Healthcare System--Similar to Canada

Feb 12, 2014

CROWN POINT,Ind.,Jan.23(UPI)--Noted oncologists call for a single-payer U.S.healthcare system--similar to Canada--because the current system is hurting cancer patients. Dr.Ray Drasga,a longtime community-based oncologist who founded a ...

Tags: healthcare system, oncologists, cancer

Validive Received a Fast Track Designation for Prevention and Treatment of Oral Mucositis

Jan 26, 2014

BioAlliance Pharma, an innovative Company dedicated to the development of orphan oncology, announced today that Validive (clonidine Lauriad) received a Fast Track designation from the US Food and Drug Administration (FDA) for the prevention ...

Tags: FDA, BioAlliance Pharma, disease, Validive

Patients with Advanced Pancreatic Cancer May Live a Little Longer

Jan 16, 2014

Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...

Tags: a

Patients with Advanced Pancreatic Cancer May Live a Little Longer

Jan 16, 2014

Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...

Tags: advanced pancreatic cancer, two therapeutic vaccines

Adding Cancer Drug Dasatinib to Therapy May Slow Progression of Advanced Breast Cancer

Dec 26, 2013

Adding the cancer drug dasatinib to standard hormone therapy may slow the progression of advanced breast cancer, a preliminary study suggests. The drug, sold under the name Sprycel, is already approved in the United States for chronic ...

Tags: cancer drug, dasatinib, hormone therapy, advanced breast cancer

Acupuncture Works No Better Than "Sham" Version of Technique in Breast-Cancer Drug Study

Dec 26, 2013

When it comes to easing the side effects of certain breast cancer drugs, acupuncture may work no better than a "sham" version of the technique, a small trial suggests. Breast cancer drugs known as aromatase inhibitors often cause side ...

Tags: breast cancer, breast cancer drugs, acupuncture, women health

Merck Serono Has Signed a License Agreement with The Spanish National Cancer Research

Dec 20, 2013

Merck Serono has signed a license agreement with the Spanish National Cancer Research Centre (CNIO) in Madrid in the area of cancer drug development and will build upon CNIO research discoveries to support the development and ...

Tags: Cancer Patients, Merck Serono

Novogen Has Announced The Filing of a Family of Provisional Patents in The US

Nov 29, 2013

Novogen, a biotechnology company, has announced the filing of a family of provisional patents in the US covering anti-tropomyosin (ATM) drug technology. ATM drugs represent an entirely novel approach to anti-cancer therapy, blocking the ...

Tags: Health, Medicine, Anti-Tropomyosin Drug Technology

The FDA Has Approved Nexavar for The Treatment of Locally Recurrent or Metastatic

Nov 26, 2013

Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...

Tags: Health, Medicine

At Least 100 Natural Cancer Cures Have Been Discovered and Used Successfully

Nov 19, 2013

"There is not one, but many cures for cancer available. But they are all being systematically suppressed by ... the major oncology centers. They have too much of an interest in the status quo," stated Dr Robert Atkins, MD, creator of the ...

Tags: Health, Medicine

CRT Has Collaborated with Danish Drug Discovery Firm Nuevolution to Develop Cancer Drugs

Nov 6, 2013

Cancer Research UK's commercial arm Cancer Research Technology (CRT) has collaborated with Danish drug discovery firm Nuevolution for the discovery of anti-cancer drug molecules targeting several key proteins. The deal is aimed at ...

Tags: Cancer Drugs, Medicine

IBM Research and IBN Discover Deliver Treatment More Efficiently to Fight Breast Cancer

Nov 5, 2013

Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...

Tags: Cancer Drug, Medicine

Eli Lilly and Company Has Received Priority Review Status From The FDA

Oct 25, 2013

Eli Lilly and Company has received priority review status from the US Food and Drug Administration (FDA) for its ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial ...

Tags: Cancer Drug, FDA Priority

Cancer Drug

Related Products